Free Fatty Acid Receptor 1 Pipeline Report: Encapsulates all the Dormant and Discontinued Pipeline Projects
Free Fatty Acid Receptor 1 Pipeline Review, H1 2018, outlays comprehensive information on the Free Fatty Acid Receptor 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administrati
(EMAILWIRE.COM, April 03, 2018 ) Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) Free fatty acid receptor 1 (FFA1), also known as GPR40, is a class A G-protein coupled receptor that is encoded by the FFAR1 gene. It is strongly expressed in the pancreatic islet cells and to a lesser extent in the brain. This membrane protein binds free fatty acids, acting as a nutrient sensor for regulating energy homeostasis.
Report Source: https://www.themarketreports.com/report/free-fatty-acid-receptor-1-g-protein-coupled-receptor-40-or-gpr40-or-ffar1-pipeline-review-h1-2018
Scope
The report provides a snapshot of the global therapeutic landscape for Free Fatty Acid Receptor 1
The report reviews Free Fatty Acid Receptor 1 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in Free Fatty Acid Receptor 1 targeted therapeutics and enlists all their major and minor projects
The report assesses Free Fatty Acid Receptor 1 targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
Purchase this report at: https://www.themarketreports.com/report/buy-now/987790
Reasons To Buy
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand the targeted therapy areas and indications for Free Fatty Acid Receptor 1
Identify the use of drugs for target identification and drug repurposing
Identify potential new clients or partners in the target demographic
Develop strategic initiatives by understanding the focus areas of leading companies
Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Free Fatty Acid Receptor 1 development landscape
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/987790
Report Source: https://www.themarketreports.com/report/free-fatty-acid-receptor-1-g-protein-coupled-receptor-40-or-gpr40-or-ffar1-pipeline-review-h1-2018
Scope
The report provides a snapshot of the global therapeutic landscape for Free Fatty Acid Receptor 1
The report reviews Free Fatty Acid Receptor 1 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in Free Fatty Acid Receptor 1 targeted therapeutics and enlists all their major and minor projects
The report assesses Free Fatty Acid Receptor 1 targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
Purchase this report at: https://www.themarketreports.com/report/buy-now/987790
Reasons To Buy
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand the targeted therapy areas and indications for Free Fatty Acid Receptor 1
Identify the use of drugs for target identification and drug repurposing
Identify potential new clients or partners in the target demographic
Develop strategic initiatives by understanding the focus areas of leading companies
Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Free Fatty Acid Receptor 1 development landscape
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/987790
Contact Information:
The Market Reports
Shirish Gupta
Tel: +1-631-407-1315
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
The Market Reports
Shirish Gupta
Tel: +1-631-407-1315
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results